Decreased expression of STING predicts poor prognosis in patients with gastric cancer

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Song, Shushu ^a   Peng, Peike ^a   Tang, Zhaoqing ^a   Zhao, Junjie ^a   Wu, Weicheng ^a   Li, Haojie ^a   Shao, Miaomiao ^a   Li, Lili ^a   Yang, Caiting ^a   Duan, Fangfang ^a   Zhang, Mingming ^a   Zhang, Jie ^a   Wu, Hao ^a   Li, Can ^a   Wang, Xuefei ^a   Wang, Hongshan ^a   Ruan, Yuanyuan ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

BITES AND STINGS; CANCER STAGING; CARCINOGENESIS; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MOLECULAR PATHOLOGY; MORTALITY; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; SIGNAL TRANSDUCTION; STOMACH TUMOR; SURVIVAL ANALYSIS; TUMOR CELL LINE; TUMOR VOLUME;

BIOMARKERS, TUMOR; BITES AND STINGS; CARCINOGENESIS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PATHOLOGY, MOLECULAR; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 85011971664     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39858     Document Type: Article

References (42)

1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87-108, doi: 10.3322/caac.21262 (2015).
2. Plummer, M., Franceschi, S., Vignat, J., Forman, D. &de Martel, C. Global burden of gastric cancer attributable to Helicobacter pylori. International journal of cancer 136, 487-490, doi: 10.1002/ijc.28999 (2015).
3. Brenkman, H. J., Haverkamp, L., Ruurda, J. P. &van Hillegersberg, R. Worldwide practice in gastric cancer surgery. World journal of gastroenterology 22, 4041-4048, doi: 10.3748/wjg.v22.i15.4041 (2016).
4. de Mestier, L., Lardiere-Deguelte, S., Volet, J., Kianmanesh, R. &Bouche, O. Recent insights in the therapeutic management of patients with gastric cancer. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, doi: 10.1016/j.dld.2016.04.010 (2016).
5. Xiao, T. S. &Fitzgerald, K. A. The cGAS-STING pathway for DNA sensing. Molecular cell 51, 135-139, doi: 10.1016/j. molcel.2013.07.004 (2013).
6. Liu, X. &Wang, C. The emerging roles of the STING adaptor protein in immunity and diseases. Immunology 147, 285-291, doi: 10.1111/imm.12561 (2016).
7. Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826-830, doi: 10.1126/science.1229963 (2013).
8. Ho, S. S. et al. The DNA Structure-Specific Endonuclease MUS81 Mediates DNA Sensor STING-Dependent Host Rejection of Prostate Cancer Cells. Immunity, doi: 10.1016/j.immuni.2016.04.010 (2016).
9. Xia, T., Konno, H., Ahn, J. &Barber, G. N. Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis. Cell reports 14, 282-297, doi: 10.1016/j.celrep.2015.12.029 (2016).
10. Nakamura, T. et al. Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma. Journal of controlled release: official journal of the Controlled Release Society 216, 149-157, doi: 10.1016/j. jconrel.2015.08.026 (2015).
11. Hartung, M. L. et al. H. pylori-Induced DNA Strand Breaks Are Introduced by Nucleotide Excision Repair Endonucleases and Promote NF-kappaB Target Gene Expression. Cell reports 13, 70-79, doi: 10.1016/j.celrep.2015.08.074 (2015).
12. Wang, Y. et al. TRIM30alpha Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING. PLoS pathogens 11, e1005012, doi: 10.1371/journal.ppat.1005012 (2015).
13. Konno, H., Konno, K. &Barber, G. N. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 155, 688-698, doi: 10.1016/j.cell.2013.09.049 (2013).
14. Ishikawa, H., Ma, Z. &Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792, doi: 10.1038/nature08476 (2009).
15. Dansako, H. et al. The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly. The FEBS journal 283, 144-156, doi: 10.1111/febs.13563 (2016).
16. Paijo, J. et al. cGAS Senses Human Cytomegalovirus and Induces Type I Interferon Responses in Human Monocyte-Derived Cells. PLoS pathogens 12, e1005546, doi: 10.1371/journal.ppat.1005546 (2016).
17. Parker, Z. M., Murphy, A. A. &Leib, D. A. Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1. Journal of virology 89, 11080-11091, doi: 10.1128/JVI.00954-15 (2015).
18. Guo, H. et al. NLRX1 Sequesters STING to Negatively Regulate the Interferon Response, Thereby Facilitating the Replication of HIV-1 and DNA Viruses. Cell host µbe 19, 515-528, doi: 10.1016/j.chom.2016.03.001 (2016).
19. Dey, B. et al. A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. Nature medicine 21, 401-406, doi: 10.1038/nm.3813 (2015).
20. Gao, D. et al. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proceedings of the National Academy of Sciences of the United States of America 112, E5699-5705, doi: 10.1073/pnas.1516465112 (2015).
21. Karimi-Googheri, M., Daneshvar, H., Khaleghinia, M., Bidaki, R. &Kazemi Arababadi, M. Decreased Expressions of STING but not IRF3 Molecules in Chronic HBV Infected Patients. Archives of Iranian medicine 18, 351-354, doi: 015186/AIM.005 (2015).
22. Anghelina, D., Lam, E. &Falck-Pedersen, E. Diminished antiviral innate response to Adenovirus vectors in cGAS/STING deficient mice minimally impacts adaptive immunity. Journal of virology, doi: 10.1128/JVI.00500-16 (2016).
23. Zhong, B. et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30, 397-407, doi: 10.1016/j.immuni.2009.01.008 (2009).
24. Liu, T. T. et al. LSm14A Plays a Critical Role in Antiviral Immune Responses by Regulating MITA Level in a Cell-Specific Manner. Journal of immunology, doi: 10.4049/jimmunol.1600212 (2016).
25. Yi, G. et al. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. PloS one 8, e77846, doi: 10.1371/journal.pone.0077846 (2013).
26. Jin, L. et al. Identification and characterization of a loss-of-function human MPYS variant. Genes and immunity 12, 263-269, doi: 10.1038/gene.2010.75 (2011).
27. Xia, T., Konno, H. &Barber, G. N. Recurrent loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis. Cancer research, doi: 10.1158/0008-5472.CAN-16-1404 (2016).
28. Barber, G. N. STING: infection, inflammation and cancer. Nature reviews. Immunology 15, 760-770, doi: 10.1038/nri3921 (2015).
29. Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S. &Weiss, S. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. The Journal of clinical investigation 120, 1151-1164, doi: 10.1172/JCI37223 (2010).
30. Andzinski, L. et al. Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. International journal of cancer 138, 1982-1993, doi: 10.1002/ijc.29945 (2016).
31. Ohkuri, T. et al. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment. Cancer immunology research 2, 1199-1208, doi: 10.1158/2326-6066.CIR-14-0099 (2014).
32. Sin, S. H. et al. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation. Journal of virology 90, 2150-2154, doi: 10.1128/JVI.02456-15 (2016).
33. Gravekamp, C. &Chandra, D. Targeting STING pathways for the treatment of cancer. Oncoimmunology 4, e988463, doi: 10.4161/2162402X.2014.988463 (2015).
34. Liang, D. et al. Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal. Biochimica et biophysica acta 1852, 2494-2503, doi: 10.1016/j.bbadis.2015.08.011 (2015).
35. Demaria, O. et al. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proceedings of the National Academy of Sciences of the United States of America 112, 15408-15413, doi: 10.1073/pnas.1512832112 (2015).
36. Jin, L. et al. STING/MPYS mediates host defense against Listeria monocytogenes infection by regulating Ly6C(hi) monocyte migration. Journal of immunology 190, 2835-2843, doi: 10.4049/jimmunol.1201788 (2013).
37. Tang, C. A. et al. Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells. Cancer research, doi: 10.1158/0008-5472.CAN-15-1885 (2016).
38. Watson, R. O. et al. The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy. Cell host µbe 17, 811-819, doi: 10.1016/j.chom.2015.05.004 (2015).
39. Corrales, L. et al. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell reports 11, 1018-1030, doi: 10.1016/j.celrep.2015.04.031 (2015).
40. Peng, P. et al. Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer. Scientific reports 6, 29604, doi: 10.1038/srep29604 (2016).
41. Chen, L. et al. Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop. Cancer research 75, 3832-3841, doi: 10.1158/0008-5472.CAN-14-3690 (2015).
42. Zhang, Y. et al. The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-beta during Chlamydia trachomatis infection. Journal of immunology 193, 2394-2404, doi: 10.4049/jimmunol.1302718 (2014).